Health Condition 1: - Health Condition 2: A305- Lepromatous leprosy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of either gender with age >18 years. 2.Leprosy patients with persistent skin lesions ,those who didnâ??t show desired response in terms of no change in skin lesions or still showing signs of disease activity in terms of infiltrated lesions or occurrence of new lesions, after completing 6 months of paucibacillary and 12 months of multibacillary MDT. 3.Patients who can give valid consent.
Exclusion criteria
Exclusion criteria: 1.Patients with lepra reaction. 2.Those who are not willing to provide consent for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To observe the clinical,Slit skin smear findings, Histopathological findings in treated cases of leprosy with persistent skin lesions after completion of 6 months of paucibacillary and 12 months of multibacillary WHO Multidrug therapy.Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the frequency of drug resistance in these patientsTimepoint: Baseline | — |
Countries
India
Contacts
PGIMER,Chandigarh